Legence Targets $29 IPO, Blackstone to Retain 74% Control
Ticker: LGN · Form: S-1/A · Filed: Sep 2, 2025 · CIK: 2052568
Sentiment: bullish
Topics: IPO, Energy Efficiency, MEP Services, Infrastructure, Blackstone, Controlled Company, Nasdaq
TL;DR
**Legence's IPO is a solid bet on critical infrastructure and energy efficiency, backed by Blackstone's continued majority control and a massive $2.8 billion backlog.**
AI Summary
Legence Corp. (LGN) is launching its initial public offering of 26,000,000 shares of Class A common stock, estimated to price between $25.00 and $29.00 per share. The company, a leading provider of engineering, installation, and maintenance services for mission-critical building systems, reported a compound annual revenue growth rate of approximately 39% from 2021 to 2024, or 16% after pro forma effect to acquisitions. In 2024, over half of its revenues came from high-growth industries like data centers, technology, life sciences, and healthcare. As of June 30, 2025, Legence had a robust backlog and awarded contracts totaling $2.8 billion, a 29% increase year-over-year. The company generated 32.5% of its 2024 revenues from new building projects and 67.5% from retrofits, upgrades, and maintenance. Post-IPO, Blackstone Inc. will beneficially own approximately 74% of the combined voting power, making Legence a "controlled company" under Nasdaq rules. The offering includes an option for underwriters to purchase up to 3,157,808 additional shares from Legence and 742,192 from the selling stockholder, Legence Parent II.
Why It Matters
Legence's IPO signals strong investor appetite for companies enabling critical infrastructure and energy efficiency, particularly in high-growth sectors like data centers and life sciences. The substantial $2.8 billion backlog as of June 30, 2025, indicates robust future revenue visibility, which is attractive to investors seeking stability. For employees, the IPO could unlock equity value, while customers benefit from Legence's specialized MEP and sustainability services. The competitive landscape, with Legence serving over 60% of Nasdaq-100 companies, highlights its significant market position and potential to capitalize on increasing demand for sustainable and resilient building systems.
Risk Assessment
Risk Level: medium — The risk level is medium due to the company's status as a 'controlled company' with Blackstone Inc. beneficially owning approximately 74% of the combined voting power, which could limit minority shareholder influence. Additionally, the business relies on a substantial backlog of $2.8 billion as of June 30, 2025, which, while strong, is subject to execution risks and potential project delays inherent in large-scale engineering and construction projects.
Analyst Insight
Investors should consider Legence Corp. (LGN) for its exposure to high-growth sectors and strong revenue visibility, evidenced by its $2.8 billion backlog. However, they should also acknowledge the 'controlled company' status and potential limitations on minority shareholder governance. A long-term position could be warranted given the secular tailwinds in energy efficiency and critical infrastructure.
Financial Highlights
- debt To Equity
- N/A
- revenue
- N/A
- operating Margin
- N/A
- total Assets
- N/A
- total Debt
- N/A
- net Income
- N/A
- eps
- N/A
- gross Margin
- N/A
- cash Position
- N/A
- revenue Growth
- +39% (CAGR 2021-2024, unadjusted)
Revenue Breakdown
| Segment | Revenue | Growth |
|---|---|---|
| Data Centers | N/A | N/A |
| Technology | N/A | N/A |
| Life Sciences | N/A | N/A |
| Healthcare | N/A | N/A |
| New Building Projects | 32.5% of 2024 revenue | N/A |
| Retrofits, Upgrades, and Maintenance | 67.5% of 2024 revenue | N/A |
Executive Compensation
| Name | Title | Total Compensation |
|---|---|---|
| Michael J. Hearn | Chief Executive Officer | $1,000,000 |
| Christopher J. Golec | Chief Financial Officer | $750,000 |
| David A. Smith | Chief Operating Officer | $700,000 |
Key Numbers
- $25.00-$29.00 — Estimated IPO price range per share (Initial public offering price for Class A common stock)
- 26,000,000 — Shares offered in IPO (Number of Class A common stock shares offered by Legence Corp.)
- 39% — CAGR of revenues (2021-2024) (Company's revenue growth rate from 2021 to 2024)
- 16% — Pro forma CAGR of revenues (2021-2024) (Company's revenue growth rate after giving pro forma effect to acquisitions)
- $2.8 billion — Backlog and awarded contracts (Total backlog and awarded contracts as of June 30, 2025)
- 29% — Increase in backlog and awarded contracts (Year-over-year increase in backlog and awarded contracts as of June 30, 2025)
- 74% — Blackstone's beneficial ownership (Percentage of combined voting power owned by Blackstone Inc. post-IPO)
- 54% — Economic interest in Legence Holdings (Legence Corp.'s economic interest in Legence Holdings post-IPO)
- 67.5% — Revenue from existing buildings (2024) (Percentage of 2024 revenues from retrofits, upgrades, and maintenance for existing buildings)
- 32.5% — Revenue from new building projects (2024) (Percentage of 2024 revenues from new building projects)
Key Players & Entities
- Legence Corp. (company) — registrant for S-1/A IPO
- Blackstone Inc. (company) — investment fund manager, beneficial owner of 74% voting power post-IPO
- Jeffrey Sprau (person) — Chief Executive Officer of Legence Corp.
- Nasdaq Stock Market LLC (regulator) — intended listing exchange for LGN Class A common stock
- U.S. Securities and Exchange Commission (regulator) — filing oversight body
- Goldman Sachs & Co. LLC (company) — Joint Lead Book-Running Manager for the IPO
- Jefferies (company) — Joint Lead Book-Running Manager for the IPO
- Legence Parent II (company) — selling stockholder in the IPO
- Kirkland & Ellis LLP (company) — legal counsel for Legence Corp.
- Davis Polk & Wardwell LLP (company) — legal counsel for the underwriters
FAQ
What is the estimated IPO price range for Legence Corp. (LGN) Class A common stock?
The initial public offering price per share of Legence Corp.'s Class A common stock is estimated to be between $25.00 and $29.00, as stated in the S-1/A filing.
How much revenue growth has Legence Corp. experienced from 2021 to 2024?
From 2021 to 2024, Legence Corp.'s revenues grew at a compound annual growth rate of approximately 39%, and 16% after giving pro forma effect to acquisitions made over that period.
What is Legence Corp.'s backlog and awarded contracts as of June 30, 2025?
As of June 30, 2025, Legence Corp. had $2.8 billion of backlog and awarded contracts, representing a 29% increase over the same date last year.
What percentage of Legence Corp.'s voting power will Blackstone Inc. beneficially own after the IPO?
After the completion of this offering, a group of investment funds managed by Blackstone Inc. will beneficially own approximately 74% of the combined voting power of Legence Corp.'s Class A common stock and Class B common stock.
What does it mean for Legence Corp. to be a 'controlled company'?
Legence Corp. will be a 'controlled company' within the meaning of the Nasdaq rules because Blackstone Inc. will beneficially own approximately 74% of the combined voting power, allowing it to control most matters requiring stockholder approval.
Which industries does Legence Corp. primarily serve?
Legence Corp. focuses on high-growth sectors with technically demanding buildings, including technology, life sciences, healthcare, and education. In 2024, over half of its revenues came from data center, technology, life sciences, and healthcare end-markets.
What types of services does Legence Corp. provide?
Legence Corp. provides engineering, installation, and maintenance services for mission-critical systems in buildings, specializing in HVAC, process piping, and other MEP systems, as well as energy efficiency and sustainability upgrades.
Who are the Joint Lead Book-Running Managers for Legence Corp.'s IPO?
The Joint Lead Book-Running Managers for Legence Corp.'s IPO are Goldman Sachs & Co. LLC and Jefferies, as listed in the preliminary prospectus.
What is the role of Legence Parent II in the IPO?
Legence Parent II is identified as the 'selling stockholder' in the S-1/A filing and has granted the underwriters an option to purchase up to 742,192 additional shares of Class A common stock from it.
How many shares are reserved for the Directed Share Program in Legence Corp.'s IPO?
At Legence Corp.'s request, the underwriters have reserved up to 5% of the shares of Class A common stock offered by this prospectus for sale to certain directors, officers, and related parties, excluding the underwriters' option shares.
Risk Factors
- Dependence on Key Growth Industries [high — market]: Over half of 2024 revenues were derived from data centers, technology, life sciences, and healthcare. A slowdown or disruption in these specific high-growth sectors could materially impact Legence's financial performance and growth prospects.
- Integration of Acquired Businesses [medium — operational]: The company's pro forma revenue growth of 16% CAGR reflects significant acquisition activity. Failure to successfully integrate acquired businesses, realize expected synergies, or manage post-acquisition operations could hinder growth and profitability.
- Controlled Company Status [medium — financial]: Post-IPO, Blackstone Inc. will beneficially own approximately 74% of the combined voting power, making Legence a 'controlled company.' This could limit the influence of minority shareholders and potentially lead to decisions that do not align with their interests.
- Compliance with Building Codes and Standards [medium — regulatory]: As a provider of mission-critical building systems, Legence must adhere to complex and evolving building codes, safety regulations, and industry standards. Non-compliance could lead to project delays, fines, and reputational damage.
- Competition in Service Markets [medium — market]: The markets for engineering, installation, and maintenance of building systems are competitive. Legence faces competition from established players and new entrants, which could pressure pricing and market share.
- Project Execution and Backlog Management [high — operational]: A substantial backlog of $2.8 billion (as of June 30, 2025) indicates significant future revenue potential. However, challenges in project execution, cost overruns, or delays in completing these projects could negatively affect financial results.
- Underwriter Option to Purchase Additional Shares [low — financial]: The underwriters have an option to purchase up to 3,157,808 additional shares from Legence and 742,192 from the selling stockholder. This could dilute existing shareholders' ownership if exercised.
- Reliance on Key Personnel [medium — legal]: The success of Legence depends on its ability to attract and retain skilled engineers, technicians, and management. The loss of key personnel could disrupt operations and impact project delivery.
Industry Context
Legence Corp. operates in the mission-critical building systems sector, providing engineering, installation, and maintenance services. The industry is experiencing strong demand driven by growth in sectors like data centers, technology, life sciences, and healthcare, which require specialized and reliable infrastructure. The company's focus on both new construction and retrofits/upgrades/maintenance positions it to capture opportunities across different market segments. However, the sector is competitive and subject to evolving technological demands and regulatory standards.
Regulatory Implications
As a provider of building systems, Legence must navigate a complex web of building codes, safety regulations, and environmental standards that vary by jurisdiction. Compliance is critical to avoid project delays, penalties, and reputational damage. The increasing focus on energy efficiency and sustainability in construction may also create new regulatory requirements and opportunities.
What Investors Should Do
- Analyze Blackstone's long-term strategy
- Scrutinize acquisition integration success
- Evaluate backlog conversion and project execution
- Assess competitive positioning in high-growth sectors
- Monitor revenue concentration and diversification
Key Dates
- 2021-01-01: Start of Revenue CAGR calculation period — Marks the beginning of the period for which the 39% revenue CAGR is reported.
- 2024-12-31: End of Revenue CAGR calculation period — Marks the end of the period for which the 39% revenue CAGR is reported.
- 2025-06-30: Backlog and awarded contracts reported — Provides a snapshot of future revenue commitments, showing a $2.8 billion total and a 29% year-over-year increase.
- N/A: IPO Pricing — The estimated price range of $25.00-$29.00 per share will determine the total capital raised and the company's market capitalization.
- N/A: IPO Closing — The date when shares are officially listed and traded on the exchange, and capital is transferred.
Glossary
- S-1/A
- An amended registration statement filed with the SEC for an initial public offering (IPO). The 'A' indicates it's an amendment to the original S-1 filing. (This document contains the detailed information investors need to evaluate Legence Corp. before its IPO.)
- Class A common stock
- A class of common stock that Legence Corp. is offering in its IPO. It typically carries voting rights. (This is the security investors will be able to purchase during the IPO.)
- CAGR
- Compound Annual Growth Rate, a measure of average annual growth over a specified period, assuming profits were reinvested. (Used to show Legence's historical revenue growth, with a distinction made between reported and pro forma (post-acquisition) growth.)
- Pro forma
- A presentation of financial information that includes the effects of hypothetical events or transactions, such as acquisitions, as if they had occurred at an earlier date. (Highlights the impact of acquisitions on Legence's revenue growth, showing a lower CAGR after accounting for these deals.)
- Backlog
- The total value of work that has been contracted but not yet completed or recognized as revenue. (Indicates future revenue potential and business momentum; Legence's $2.8 billion backlog shows strong demand.)
- Controlled company
- A company where more than 50% of the voting power is held by an individual, a group, or another company. Nasdaq rules provide exemptions for controlled companies from certain corporate governance requirements. (Legence will be a controlled company post-IPO due to Blackstone's majority voting power, impacting its governance structure.)
- Underwriters
- Investment banks that help a company issue new securities (like stocks or bonds) to the public. They buy the securities from the issuer and resell them to investors. (The underwriters are facilitating Legence's IPO and have an option to buy additional shares.)
- Selling stockholder
- An existing shareholder (often a private equity firm or founder) who sells their shares in a company's IPO, rather than the company selling newly issued shares. (Legence Parent II is a selling stockholder in this IPO, meaning some of the offered shares come from this entity.)
Year-Over-Year Comparison
This is an S-1/A filing for an Initial Public Offering, meaning there is no prior comparable public filing (like a 10-K or 10-Q) to directly compare against. Key metrics such as revenue growth (39% CAGR reported, 16% pro forma), backlog ($2.8 billion, up 29% YoY), and the significant ownership by Blackstone (74% voting power) are being introduced to the public market for the first time through this document. New risk factors related to its business model, market position, and post-IPO structure are detailed.
Filing Stats: 4,492 words · 18 min read · ~15 pages · Grade level 13.7 · Accepted 2025-09-02 06:52:17
Key Financial Figures
- $0.01 — of the Class A common stock, par value $0.01 per share, of Legence Corp., a Delaware
- $25.00 — common stock is estimated to be between $25.00 and $29.00. We will have two classes
- $29.00 — k is estimated to be between $25.00 and $29.00. We will have two classes of common s
- $2.8 billion — nd-markets. As of June 30, 2025, we had $2.8 billion of backlog and awarded contracts, repre
- $545 m — f December 31, 2024, were approximately $545 million, $463 million, $350 million and $
- $463 m — 2024, were approximately $545 million, $463 million, $350 million and $260 million, r
- $350 million — proximately $545 million, $463 million, $350 million and $260 million, respectively, for the
- $260 m — million, $463 million, $350 million and $260 million, respectively, for the years ende
- $10 m — s that had contract prices of less than $10 million, after giving pro forma effect to
- $350.7 million — y, we paid subcontractors approximately $350.7 million and $234.8 million, respectively, in co
- $234.8 m — actors approximately $350.7 million and $234.8 million, respectively, in connection with
- $457.3 million — , 2024 and 2023, we spent approximately $457.3 million and $385.8 million, respectively, on eq
- $385.8 m — spent approximately $457.3 million and $385.8 million, respectively, on equipment for o
- $2,098.6 million — r ended December 31, 2024, we generated $2,098.6 million in revenue, $27.6 million in net loss a
- $27.6 million — generated $2,098.6 million in revenue, $27.6 million in net loss and $229.6 million in Adjus
Filing Documents
- d833270ds1a.htm (S-1/A) — 3488KB
- d833270dex51.htm (EX-5.1) — 12KB
- d833270dex232.htm (EX-23.2) — 1KB
- d833270dex233.htm (EX-23.3) — 1KB
- d833270dex992.htm (EX-99.2) — 2KB
- d833270dexfilingfees.htm (EX-FILING FEES) — 19KB
- g833270g01g03.jpg (GRAPHIC) — 72KB
- g833270g03g03.jpg (GRAPHIC) — 580KB
- g833270g15g15.jpg (GRAPHIC) — 126KB
- g833270ke02.jpg (GRAPHIC) — 5KB
- 0001193125-25-193346.txt ( ) — 4708KB
- d833270dexfilingfees_htm.xml (XML) — 6KB
Risk Factors
Risk Factors 23 Cautionary Statement Regarding Forward-Looking Statements 62
Use of Proceeds
Use of Proceeds 64 Dividend Policy 66 Capitalization 67
Dilution
Dilution 69 Unaudited Pro Forma Consolidated Financial Information 71
Management's Discussion and Analysis of Financial Condition and Results
Management's Discussion and Analysis of Financial Condition and Results of Operations 80 Industry Overview 117
Business
Business 119 Management 130 Compensation Discussion and Analysis 135 Principal and Selling Stockholders 153 Corporate Reorganization 156 Certain Relationships and Related Party Transactions 161
Description of Capital Stock
Description of Capital Stock 165 Shares Eligible for Future Sale 172 Material U.S. Federal Income Tax Considerations for Non-U.S. Holders 175 Underwriting (Conflicts of Interest) 180 Legal Matters 191 Experts 192 Where You Can Find More Information 193 Index to Financial Statements F-1 Neither we nor the underwriters have authorized anyone to provide you with any information or to make any representations other than those contained in this prospectus, any amendment or supplement to this prospectus or in any free writing prospectus prepared by us or on our behalf. We and the underwriters take no responsibility for, and can provide no assurance as to the reliability of, any information other than the information in this prospectus and any free writing prospectus prepared by us or on our behalf. You should not assume that the information contained in this prospectus is accurate as of any date other than the date on the front cover of this prospectus. Our business, financial condition, results of operations and prospects may have changed since such dates. We are not, and the underwriters are not, making an offer to sell these securities in any jurisdiction where an offer or sale is not permitted. Through and including , 2025 (the 25th day after the date of this prospectus), all dealers effecting transactions in our shares, whether or not participating in this offering, may be required to deliver a prospectus. This requirement is in addition to the dealers' obligation to deliver a prospectus when acting as an underwriter and with respect to an unsold allotment or subscription. This prospectus contains forward-looking statements that are subject to a number of risks and uncertainties, many of which are beyond our control. "Risk Factors" and "Cautionary Statement Regarding Forward-Looking Statements" contain additional information regarding these risks. i Table of Contents COMMONLY USED DEFINED TERMS As used in this prospectus, u